Every material Form 8-K Genworth Financial has filed with the SEC since July 31, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Genworth reported a third-quarter 2026 net loss of $41 million, or $0.11 per diluted share, compared with net income of $116 million a year earlier. Adjusted operating income excluding the Closed Block was $102 million, or $0.27 per diluted share, down from $113 million a year earlier, and the company authorized a new $500 million share repurchase program.
GAAP net loss of $41 million ($0.11 per diluted share) versus net income of $116 million ($0.28) in Q3 2025 and $47 million in Q2 2026
Adjusted operating income excluding Closed Block was $102 million ($0.27 per share), versus $113 million ($0.28) a year earlier
Closed Block adjusted operating loss of $146 million, driven by a $111 million pre-tax A/E loss from lower terminations and higher benefit utilization
Enact adjusted operating income of $132 million; Genworth repurchased $80 million of shares in the quarter and announced a new $500 million authorization
Genworth Financial said President and CEO Thomas J. McInerney will retire and leave its board effective December 31, 2026. Jerome T. Upton, the company's CFO, will become President and CEO and join the board effective January 1, 2027, and Angela R. Simmons will become Executive Vice President and CFO on the same date.
Thomas J. McInerney retires as President and CEO and resigns from the board effective December 31, 2026.
Jerome T. Upton, currently CFO, is to become President and CEO and a board member effective January 1, 2027.
Angela R. Simmons, currently CFO of the Closed Block, is to become Executive Vice President and CFO effective January 1, 2027.
The filing says McInerney's retirement is not the result of any disagreement with the company, and compensation terms for Upton and Simmons will be disclosed later by amendment.
Genworth Financial said its Vice President and Controller, Darren W. Woodell, who serves as principal accounting officer, intends to resign to pursue a new opportunity, effective in early November 2026 after the Form 10-Q for the period ending September 30, 2026 is filed. The filing states the resignation is not due to any disagreement with the company on operations, policies or practices. Chief Financial Officer Jerome T. Upton will serve as interim principal accounting officer until a successor is appointed, a change that is administrative in nature for shareholders.
Darren W. Woodell notified Genworth of his intent to resign on October 8, 2026
Departure is effective in early November 2026, after the Form 10-Q for the period ending September 30, 2026 is filed
Jerome T. Upton, Executive Vice President and CFO, will serve as interim principal accounting officer
Upton's compensatory arrangements will not change; his details are incorporated by reference from the April 6, 2026 Proxy Statement
Genworth Financial said Thomas J. McInerney will return from a leave of absence and resume the role of President and Chief Executive Officer effective September 2, 2026. Jerome T. Upton, who has been interim President and CEO, will stop serving in that capacity on the same date and remain Executive Vice President and Chief Financial Officer.
Thomas J. McInerney resumes the President and CEO role effective September 2, 2026
He will resume day-to-day operational responsibilities and serve as principal executive officer
Jerome T. Upton ends his interim CEO role on September 2, 2026 and remains Executive Vice President and CFO
Genworth reported second quarter 2026 net income available to common stockholders of $47 million, or $0.12 per diluted share, flat with the prior quarter and down from $51 million a year earlier. Adjusted operating income excluding Closed Block was $112 million, or $0.29 per diluted share, up from $0.27 a year earlier, while the Closed Block segment posted an adjusted operating loss of $110 million driven by a $127 million pre-tax A/E loss.
Net income of $47 million, or $0.12 per diluted share, versus $51 million, or $0.12, in Q2 2025
Adjusted operating income excluding Closed Block of $112 million, or $0.29 per diluted share, versus $0.27 in Q2 2025
Closed Block adjusted operating loss of $110 million, compared with a loss of $44 million in Q2 2025
Enact reported adjusted operating income of $143 million and holding company cash and liquid assets of $215 million; Genworth repurchased $62 million of shares at an average price of $8.74
Genworth Financial said CEO Thomas McInerney is taking a temporary leave of absence to focus on his health. CFO Jerome Upton, who has been with the company since 1998, was named Interim President and Chief Executive Officer effective July 7, 2026. The filing does not describe how long the leave will last or any change to the company's strategy.
Thomas J. McInerney, President and CEO, began a temporary leave of absence on July 7, 2026 to focus on his health
Jerome T. Upton, 62, CFO since March 2023, was appointed Interim President and CEO effective July 7, 2026
Board Chair Melina Higgins said the company plans to continue executing its existing strategy during the interim period
Genworth reported first-quarter 2026 net income available to common stockholders of $47 million, or $0.12 per diluted share, compared with $54 million, or $0.13 per diluted share, a year earlier. Adjusted operating income excluding the Closed Block was $109 million, or $0.28 per diluted share, versus $114 million, or $0.27, in the first quarter of 2025, while total revenues were $1,777 million against $1,786 million a year earlier.
Net income available to common stockholders was $47 million ($0.12 per diluted share), versus $54 million ($0.13) in Q1 2025 and $2 million in Q4 2025.
Adjusted operating income excluding Closed Block was $109 million ($0.28 per diluted share), versus $114 million ($0.27) in Q1 2025 and $122 million ($0.31) in Q4 2025.
Enact reported adjusted operating income of $140 million; the Closed Block reported a $32 million adjusted operating loss.
Genworth repurchased $66 million of shares at an average price of $8.61 per share in the quarter, and held $166 million in holding company cash and liquid assets at March 31, 2026.
Genworth Financial reported fourth-quarter 2025 net income available to common stockholders of $2 million, or $0 per diluted share, down from $116 million in the third quarter and a $1 million loss a year earlier. For full-year 2025, net income was $223 million, or $0.54 per diluted share, compared with $299 million in 2024, and adjusted operating income was $144 million, or $0.35 per diluted share, versus $273 million in 2024, which lowers per-share earnings for shareholders.
Q4 2025 adjusted operating income was $8 million, or $0.02 per diluted share, versus $17 million in Q3 2025 and $15 million in Q4 2024.
Q4 2025 total revenues were $1,784 million, compared with $1,782 million a year earlier and $1,935 million in Q3 2025.
Closed Block adjusted operating loss was $114 million in Q4 2025, up from $96 million in Q3 2025, with the long-term care insurance loss at $159 million.
Enact reported Q4 2025 adjusted operating income of $146 million; in February 2026, Enact announced a share repurchase program of up to $500 million.
Enact Holdings, a publicly traded subsidiary of Genworth Financial, issued a press release on February 3, 2026 with its results for the quarter ended December 31, 2025, furnished as Exhibit 99.1. This 8-K does not state any revenue, profit, or guidance figures, so the filing alone does not show how those results compare with prior periods. Genworth plans to release its own quarterly results after the market closes on February 23, 2026.
Enact Holdings (Nasdaq: ACT) released results for the quarter ended December 31, 2025 on February 3, 2026, in Exhibit 99.1.
Genworth Financial will issue its quarterly earnings release after market close on February 23, 2026.
Genworth will hold a conference call on February 24, 2026 at 9:00 a.m. ET to discuss the quarter.
Genworth reported third-quarter 2025 net income available to common stockholders of $116 million, or $0.28 per diluted share, up from $51 million in the prior quarter and $85 million a year earlier. Adjusted operating income fell to $17 million, or $0.04 per diluted share, from $68 million in the prior quarter and $48 million a year earlier. The company also announced a new $350 million share repurchase authorization, and the GAAP result was helped by $78 million of net investment gains and a $34 million tax benefit.
Net income available to common stockholders was $116 million ($0.28 diluted), versus $51 million in Q2 2025 and $85 million in Q3 2024.
Adjusted operating income was $17 million ($0.04 diluted), versus $68 million in Q2 2025 and $48 million in Q3 2024.
Net income included a $34 million tax benefit and $78 million of net investment gains; Long-Term Care Insurance adjusted operating loss was $100 million.
Board authorized a new $350 million share repurchase program; $76 million was executed in the quarter.
Genworth reported second-quarter 2025 results, with net income available to common stockholders of $51 million, or $0.12 per diluted share, compared with $76 million, or $0.17, a year earlier. Adjusted operating income was $68 million, or $0.16 per diluted share, down from $125 million a year earlier but up from $51 million in the first quarter of 2025, and total revenues rose slightly year over year to $1,796 million.
Net income available to common stockholders was $51 million ($0.12 per diluted share) in Q2 2025, versus $76 million ($0.17) in Q2 2024 and $54 million ($0.13) in Q1 2025.
Adjusted operating income was $68 million ($0.16 per diluted share), versus $125 million ($0.28) in Q2 2024 and $51 million ($0.12) in Q1 2025.
Total revenues were $1,796 million, compared with $1,786 million in Q2 2024.
Genworth repurchased $30 million of shares in the quarter, leaving $80 million remaining in the authorization at June 30, 2025.
Genworth reported first quarter 2025 net income of $54 million, or $0.13 per diluted share, down from $139 million, or $0.31 per diluted share, in the first quarter of 2024. Adjusted operating income was $51 million, or $0.12 per diluted share, compared with $85 million, or $0.19, a year earlier, though it improved from $15 million in the fourth quarter of 2024. The results show lower earnings year over year, with Enact the main earnings contributor.
Net income $54 million ($0.13 per diluted share) in Q1 2025 vs. $139 million ($0.31) in Q1 2024 and a $1 million loss in Q4 2024
Adjusted operating income $51 million ($0.12 per diluted share) vs. $85 million ($0.19) in Q1 2024
Enact raised its quarterly dividend to $0.21 per share from $0.185 and announced a new buyback authorization of up to $350 million
Holding company cash and liquid assets were $211 million at March 31, 2025, down from $294 million at December 31, 2024
Genworth Financial increased its board to 10 directors and elected Steven C. Van Wyk, former Group Chief Information Officer of HSBC, as a new independent director effective March 19, 2025. The filing says he will stand for election at the 2025 Annual Meeting of Stockholders on May 22, 2025, and the board has not yet set his committee assignments.
Board size increased from 9 to 10 directors; Van Wyk elected March 19, 2025
Van Wyk was Group CIO of HSBC; he retired in 2024 and previously held CIO roles at PNC, ING and Morgan Stanley
Van Wyk will stand for election at the Annual Meeting of Stockholders scheduled for May 22, 2025
Board determined he is independent under NYSE listing standards; committee appointments to be decided later
Genworth reported fourth-quarter 2024 net loss of $1 million, or breakeven per diluted share, compared with a $212 million loss a year earlier but down from $85 million of net income in the third quarter. Full-year 2024 net income was $299 million, or $0.68 per diluted share, up from $76 million in 2023, while quarterly total revenues fell to $1.78 billion from $1.91 billion.
Q4 2024 adjusted operating income was $15 million, or $0.04 per diluted share, versus a $230 million loss in Q4 2023 and $48 million in Q3 2024.
Full-year 2024 adjusted operating income was $273 million, or $0.62 per diluted share, compared with $41 million in 2023.
Enact reported Q4 2024 adjusted operating income of $137 million; Long-Term Care Insurance adjusted operating loss was $104 million.
The company repurchased $51 million of common stock in Q4 2024 and $565 million program-to-date through February 14, 2025.
Enact Holdings, Inc., a publicly traded subsidiary of Genworth Financial, released its financial results for the quarter ended December 31, 2024, on February 4, 2025, attached as Exhibit 99.1. The filing contains no figures from those results, so its performance cannot be judged from this 8-K alone.
Enact Holdings (Nasdaq: ACT) issued its Q4 2024 results press release on February 4, 2025
Genworth plans to release its quarter ended December 31, 2024 earnings after market close on February 18, 2025
Genworth's earnings conference call is scheduled for February 19, 2025 at 9:00 a.m. ET
Genworth reported third-quarter 2024 net income available to common stockholders of $85 million, or $0.19 per diluted share, up from $29 million a year earlier and $76 million in the prior quarter. Adjusted operating income was $48 million, or $0.11 per diluted share, down from $125 million in the second quarter but up from $42 million a year earlier, with the Enact mortgage insurance segment the main contributor.
Q3 2024 net income $85 million ($0.19 diluted EPS), vs. $76 million ($0.17) in Q2 2024 and $29 million ($0.06) in Q3 2023
Adjusted operating income $48 million ($0.11 per diluted share), vs. $125 million in Q2 2024 and $42 million in Q3 2023
Total revenues $1.88 billion, vs. $1.83 billion in Q2 2024 and $1.77 billion in Q3 2023
Enact adjusted operating income $148 million; Genworth repurchased $36 million of stock in the quarter and $503 million program-to-date through October
Genworth Financial reported second-quarter 2024 results on July 31, 2024. Net income available to common stockholders was $76 million, or $0.17 per diluted share, down from $139 million in the prior quarter, while adjusted operating income rose to $125 million, or $0.28 per diluted share, from $85 million. The mixed picture matters to shareholders because GAAP profit fell while the company's non-GAAP measure improved, and the results were driven by Enact and offset by losses in long-term care insurance and net investment losses.
Net income available to common stockholders was $76 million ($0.17 per diluted share) in Q2 2024, versus $139 million in Q1 2024.
Adjusted operating income was $125 million ($0.28 per diluted share), versus $85 million in Q1 2024 and $85 million in Q2 2023.
Net investment losses, net of taxes, reduced net income by $48 million in the quarter.
Company repurchased $36 million of common stock in the quarter; $111 million executed year-to-date through July 31, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Genworth Financial filing is on SEC EDGAR ↗. 8-K briefs of other companies →